VESOXX sol 10 mg/10ml 100 x 10 ml
7680679830011
CH-67983
G04BD04
05.02.0.
Reimbursement limitations:
VESOXX.01
Vesoxx est remboursé pour inhiber l'hyperactivité du détrusor due à une lésion de la moelle …
1 / 3
google
Details
- Product number
- 6798301
- CPT
- -
- Packaging group
- 100
- Unit
- Fertigspritze(n)
- Composition
- oxybutynini hydrochloridum 1.004 mg corresp. oxybutyninum 0.911 mg, acidum hydrochloridum dilutum, natrii chloridum corresp. natrium 3.56 mg, aqua purificata, ad solutionem pro 1 ml.
Articles (1)
Vesoxx 1 mg/ml, Lösung zur Intravesikalen Anwendung
Lösung
100
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
1.004 MG | Substance | WIZUS |
|
(N/A)
|
0.911 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
3.56 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
Melisana AG
8004 Zürich
Authorization information
- Swissmedic authorization number
- 67983
- Drug name
- Vesoxx, Lösung zur intravesikalen Anwendung
- Galenic form
- LSIV
- ATC Code
- G04BD04
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 27/05/2021
- Authorization expiration date
- 31/12/9999
- IT number
- 05.02.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- VESOXX sol 10 mg/10ml 100 x 10 ml
- Description (DE)
- VESOXX Lös 10 mg/10ml 100 x 10 ml
- Market launch
- 27/05/2021
- Narcotic (BTM)
- No